CORRECTING and REPLACING DocGo Expands Mobile Health Services to Empire BlueCross BlueShield Members
Leading Mobile Health Services and Transportation Provider Expands New York Presence, Brings In-home Medical Care…
News
GCC (Gulf Cooperation Council) Color Cosmetics Market Report 2022: Latest Trends, Competition Analysis, and Business Opportunities, 2022-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “GCC Color Cosmetics Market Report: By Type, Product, Packaging, Consumer Group, Distribution Channel…
CoreStack & Persistent Announce Global Partnership to Accelerate Digital Transformation in Multi-Cloud Environments
CoreStack’s Next-Gen Cloud Governance Powers the Persistent Intelligent Operations Solution BELLEVUE, Wash. & SANTA CLARA,…
RealPage® Earns 2022 ENERGY STAR® Partner of the Year Award
EPA, Department of Energy recognize real estate innovator’s outstanding sustainability achievements for the second consecutive…
OneReach.ai Receives Highest Scores in Customer Service and Human Resources Use Cases in the Inaugural 2022 Gartner® Critical Capabilities for Enterprise Conversational AI Platforms Report
DENVER–(BUSINESS WIRE)–#AI—OneReach.ai, creators of a market-leading platform that’s democratizing conversational AI and machine learning with…
ServiceNow Ecosystem Helps U.S. Firms Rein in Complexity
The fast-growing workflow platform is easing application and function sprawl at U.S. enterprises in many…
JPMorgan Chase Launches Advancing Black Wealth Tour to Promote Generational Wealth-Building in Black Communities
Tour to offer insights on financial health, the path to homeownership and entrepreneurship in Los…
TEOCO joins Google Cloud Partner Advantage Program
FAIRFAX, VA., USA – 5 May 2022 – TEOCO, the leading provider of analytics, assurance…
Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial
The IND application for this pilot trial to evaluate oral growth hormone secretagogue, LUM-201, in…
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
– $209.7 Million Cash and Cash Equivalents at March 31, 2022 – – Over 120…
Turning Point Therapeutics Announces Pipeline Expansion, Licensing of TPX-4589 (LM-302), A Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate for Gastrointestinal Cancers, From Lanova Medicines
Strategic Expansion of Turning Point Precision Oncology Portfolio TPX-4589 (LM-302) Currently in Two Ongoing Phase…
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022
Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from…
Hillstream BioPharma to Present at BioNJ’s 12th Annual BioPartnering Virtual Conference Held on May 9- 13, 2022
Developed in partnership with J.P. Morgan and Johnson & Johnson Innovation, the Conference will bring…
Enlivex Announces Issuance of Two U.S. Patents Covering Methods of Treating Sepsis with Allocetra
Nes-Ziona, Israel, May 05, 2022 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Coherus BioSciences Appoints Charlie Newton to Board of Directors
– Biotechnology Chief Financial Officer and highly regarded former healthcare investment banker brings decades of…
Palisade Bio and Newsoara Receive NMPA Clearance to Commence Phase 3 Clinical Trial in China Evaluating LB1148 to Accelerate the Return of Bowel Function Following Abdominal Surgery
NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S….
Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education
Live Demonstration of New RhodoLED® XL to be Featured WOBURN, Mass., May 05, 2022 (GLOBE…
Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors
Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharma NEW YORK, May 05, 2022…
ABVC BioPharma Announces Streamlined Vitargus® Manufacturing Process
New Process Improves Quality and Lowers Cost Fremont, CA, May 05, 2022 (GLOBE NEWSWIRE) —…
Wave Life Sciences to Webcast Conference Call of First Quarter 2022 Financial Results on May 12, 2022
CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…